Earnings History Data for Legend Biotech Corporation (LEGN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Legend Biotech Corporation
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | PM | LEGN | Legend Biotech Corporation | 7,280 | -0.34 | -0.56 | -0.17 | Legend Biotech GAAP EPS of -$0.34, revenue of $160.21M [11/12/2024 7:08 AM] |
40.10 | 0.06 (0.15%) |
40.51 | 0.47 (1.17%) |
38.60 - 70.13 | 1,625,414 | 1,650,000 | 13,919 | ||
|
||||||||||||||||||
| 09-08-2024 | PM | LEGN | Legend Biotech Corporation | 10,020 | -0.05 | -0.54 | -0.27 | Legend Biotech GAAP EPS of -$0.05 beats by $0.21, revenue of $186.52M beats by $60.41M [8/9/2024 7:05 AM] |
55.86 | -1.05 (-1.85%) |
59.24 | 2.33 (4.09%) |
38.60 - 72.62 | 687,239 | 840,000 | 9,752 | ||
| 13-05-2024 | PM | LEGN | Legend Biotech Corporation | 8,280 | -0.16 | -0.28 | -0.40 | Legend Biotech GAAP EPS of -$0.16 beats by $0.02, revenue of $93.99M misses by $47.37M [5/13/2024 7:04 AM] |
43.00 | -0.24 (-0.56%) |
46.22 | 2.98 (6.89%) |
42.08 - 77.32 | 1,207,338 | 870,000 | 6,431 | ||
| 11-03-2024 | PM | LEGN | Legend Biotech Corporation | 10,600 | -0.40 | -0.70 | 0.00 | Legend Biotech GAAP EPS of -$0.40 misses by $0.10, revenue of $79.46M misses by $16.2M [3/11/2024 7:01 AM] |
64.99 | 1.74 (2.75%) |
64.50 | 1.25 (1.98%) |
43.03 - 77.32 | 1,265,558 | 750,000 | 2,133 | ||
| 20-11-2023 | PM | LEGN | Legend Biotech Corporation | 10,490 | -0.17 | -0.56 | 0.00 | Legend Biotech GAAP EPS of -$0.17 beats by $0.14, revenue of $96.01M misses by $3.5M [11/20/2023 6:03 AM] |
60.43 | -4.13 (-6.40%) |
65.21 | 0.65 (1.01%) |
42.90 - 77.32 | 1,222,316 | 640,000 | 16,973 | ||
| 15-08-2023 | PM | LEGN | Legend Biotech Corporation | 11,770 | -0.27 | -0.69 | -0.41 | Legend Biotech GAAP EPS of -$0.57 misses by $0.20, revenue of $73.33M beats by $17.09M [8/15/2023 6:04 AM] |
66.86 | -3.49 (-4.97%) |
68.75 | -1.60 (-2.27%) |
37.30 - 77.32 | 1,372,831 | 500,000 | 3,199 | ||
| 18-05-2023 | PM | LEGN | Legend Biotech | 12,009 | -0.40 | -0.56 | 0.00 | Legend Biotech GAAP EPS of -$0.34, revenue of $36.3M [5/18/2023 8:56 AM] |
69.02 | -2.33 (-3.27%) |
0.0 | 0.0 (0.00%) |
37.30 - 73.30 | 456,735 | 600,000 | 0 | ||
| 01-06-2022 | PM | LEGN | Legend Biotech Corporation | 6,070 | -0.24 | -0.37 | -0.30 | Legend Biotech GAAP EPS of -$0.13, revenue of $40.83M [6/1/2022 8:42 AM] |
42.59 | 0.30 (0.71%) |
42.29 | 0.0 (0.00%) |
30.75 - 58.00 | 452,481 | 450,000 | 99,651 | ||
|
||||||||||||||||||
| 18-03-2022 | AH | LEGN | Legend Biotech Corporation | 5,450 | -0.38 | -0.35 | -0.22 | Legend Biotech GAAP EPS of -$0.30 beats by $0.14, revenue of $39M beats by $24.78M [3/18/2022 4:03 PM] |
38.29 | -0.24 (-0.62%) |
37.30 | -1.23 (-3.19%) |
25.40 - 58.00 | 769,058 | 768,023 | 913 | ||
| 16-11-2021 | PM | LEGN | Legend Biotech Corporation | 6,940 | -0.43 | -0.35 | -0.25 | Legend Biotech EPS misses by $0.08, beats on revenue [11/16/2021 8:50 AM] |
52.64 | 3.53 (7.19%) |
51.98 | 2.87 (5.84%) |
23.41 - 58.00 | 586,838 | 600,000 | 3,495 | ||
| 23-08-2021 | PM | LEGN | Legend Biotech Corporation Sponsored Adr | 5,107 | -0.32 | -0.31 | 0.00 | Legend Biotech EPS misses by $0.02, beats on revenue [8/23/2021 8:15 AM] |
37.56 | 2.18 (6.15%) |
36.30 | 0.92 (2.60%) |
23.41 - 49.49 | 434,452 | 360,000 | 714 | ||
| 18-03-2021 | PM | 7:00 AM ET (Mar 18) |
LEGN | Legend Biotech Corporation | 3,370 | -0.22 | -0.28 | 0.00 | Legend Biotech EPS beats by $0.08, beats on revenue [3/18/2021 7:06 AM] |
26.22 | -2.09 (-7.38%) |
28.60 | 0.29 (1.02%) |
23.41 - 43.24 | 229,139 | 530,000 | 1,021 | |